Great Lakes Regional Center of Excellence

Great Lakes Regional Center of Excellence

Skip to: main navigation | utility navigation | main content

#

Welcome

The GLRCE is committed to funding development of new vaccines, therapeutics and diagnostics to counteract diseases caused by bio-threat agents via the combined research excellence of inter-disciplinary scientists in the Great Lakes region.

GLRCE News

#

Biosafety scholarship

Training Program Objective: establish and supervise biosafety programs in a variety of research settings, especially those with associated biocontainment facilities.

For MD, PhD, DVM or other professional degree, preferably in life sciences.

More details on the biosafety scholarship program



#

Galveston National Laboratory

GNL provides much needed research space and specialized research capabilities to develop therapies, vaccines, and diagnostic tests for naturally occurring emerging diseases such as SARS, West Nile encephalitis and avian influenza.

Service Brochure
GNL Website


#

Announcement of the three Microbial Sequencing Centers awards

The Broad Institute, J. Craig Venter Institute and the University of Maryland, Baltimore are the three Microbial Sequencing Centers that have just been awarded contracts

More details on the News page ».


#

GLRCE researchers will conduct collaborative research in the new Howard T. Ricketts Regional Biocontainment Laboratory being constructed by the University of Chicago at Argonne National Laboratory. More information about the lab can be found here.
Information about other NIH/NIAID funded RCEs may be found here.

New PHS 398 Forms from the NIH (mandatory as of May 2008)
More links to external resources may be found on the Links page.



Latest Publications

Ragle BE, Bubeck Wardenburg J. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:2712-8.
Pubmed Abstract
PMID: 19380475

Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. 2009. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48:5631-41.
Pubmed Abstract
PMID: 19476346

Additonal publications »

 

NIH Public Access Policy required for RCE funded publications.

List of Journals that process compliancy to public access policy on behalf of authors.
NIH Resources related to Public Access Policy (including submission process for new publications)

#